The Pharmaceutical Journal
Vol 276 No 7388 p196
18 February 2006

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Call for post-market studies

Prospective observational studies should be carried out for every medicine when it is first marketed, says Portsmouth University's Drug Safety Research Unit.

After reviewing drug withdrawals in the UK and US markets from 1999 to 2001 the DSRU concluded that only two products were withdrawn because of evidence for a patient-relevant outcome from comparative studies.